Document is current
Any future updates will be listed below
-
Authors
Wilke, Carlo https://orcid.org/0000-0002-7250-8597
Haas, Eva
Reetz, Kathrin
Faber, Jennifer
Garcia‐Moreno, Hector
Santana, Magda M
van de Warrenburg, Bart
Hengel, Holger
Lima, Manuela
Filla, Alessandro
Durr, Alexandra
Melegh, Bela
Masciullo, Marcella
Infante, Jon
Giunti, Paola
Neumann, Manuela
de Vries, Jeroen
Pereira de Almeida, Luis https://orcid.org/0000-0001-5831-3307
Rakowicz, Maria
Jacobi, Heike
Schüle, Rebecca
Kaeser, Stephan A
Kuhle, Jens
Klockgether, Thomas
Schöls, Ludger
,
Barro, Christian
Hübener‐Schmid, Jeannette
Synofzik, Matthis https://orcid.org/0000-0002-2280-7273
Deuschle, Christian
Stransky, Elke
Brockmann, Kathrin
Schulz, Jörg B
Baliko, Laszlo
van Gaalen, Judith
Raposo, Mafalda
Jeromin, Andreas
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (779257)
EC | Horizon 2020 Framework Programme (643417)
National Ataxia Foundation
Wilhelm Vaillant Stiftung
NKFIH (119540)
- License Information
-
More Information
Article History
Received: 22 November 2019
Revised: 5 May 2020
Accepted: 10 May 2020
First Online: 8 June 2020
Conflict of interest
: BW receives research funding from Radboud university medical centre, ZonMW, Hersenstichting and Gossweiler Foundation. MR receives funding from the Polish National Center for Research and Development (grant IS‐2/230/NCBR/2015). TK receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the German Federal Ministry of Education and Research (BMBF), the German Federal Ministry of Health (BMG), the Robert Bosch Foundation, the European Union (EU), and the National Institutes of Health (NIH). He has received consulting fees from Biohaven and UBC. He has received a speaker honorarium from Novartis. MS received speaker's honoraria and research support from Actelion Pharmaceuticals, unrelated to the current project and manuscript. The other authors declare no competing financial interests.
